De novo malignancy after kidney transplantation

DOI
  • OKABE Yasuhiro
    Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
  • NAKAMURA Masafumi
    Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University

Bibliographic Information

Other Title
  • 腎移植後de novo悪性腫瘍

Description

<p>Kidney transplantation is improving quality of life as well as life expectancy. However, immunosuppressive drugs after kidney transplantation are increasing the standardized incidence ratio and cumulative incidence of malignant tumors. Malignancies have also recently become the leading cause of death among kidney transplant recipients. In recent years, the frequency of malignancy is increasing due to the long-term viability and survival of kidney transplant recipients and the increasing potency of immunosuppressive drugs. Malignancy control is needed to further improve the outcome of kidney transplantation. In this article, we would like to clarify the characteristics, screenings and managements of de novo malignancy after kidney transplantation.</p>

Journal

Keywords

Details 詳細情報について

  • CRID
    1390865286992296192
  • DOI
    10.11386/jst.59.2_157
  • ISSN
    21880034
    05787947
  • Text Lang
    ja
  • Data Source
    • JaLC
  • Abstract License Flag
    Disallowed

Report a problem

Back to top